相似文献
1
Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.
Neurology. 2013 Jan 29;80(5):492-5. doi: 10.1212/WNL.0b013e31827f0ebb. Epub 2013 Jan 9.
2
The roles of hypoxia-inducible Factor-1 and iron regulatory protein 1 in iron uptake induced by acute hypoxia.
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):128-135. doi: 10.1016/j.bbrc.2018.10.185. Epub 2018 Nov 8.
3
Iron Regulatory Protein 1 Suppresses Hypoxia-Induced Iron Uptake Proteins Expression and Decreases Iron Levels in HepG2 Cells.
J Cell Biochem. 2015 Sep;116(9):1919-31. doi: 10.1002/jcb.25147.
4
Pathological changes in Sertoli cells and dysregulation of divalent metal transporter 1 with iron responsive element in the testes of idiopathic azoospermia patients.
Andrologia. 2018 Mar;50(2). doi: 10.1111/and.12878. Epub 2017 Aug 1.
5
Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1.
Blood Cells Mol Dis. 2002 Nov-Dec;29(3):488-97. doi: 10.1006/bcmd.2002.0587.
6
Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.
Cell Res. 2010 Mar;20(3):345-56. doi: 10.1038/cr.2010.20. Epub 2010 Feb 2.
7
Cell death induced by mitochondrial complex I inhibition is mediated by Iron Regulatory Protein 1.
Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2202-2209. doi: 10.1016/j.bbadis.2017.05.015. Epub 2017 May 11.
8
Aging-related changes in the iron status of skeletal muscle.
Exp Gerontol. 2013 Nov;48(11):1294-302. doi: 10.1016/j.exger.2013.08.011. Epub 2013 Aug 29.
9
Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.
Biochim Biophys Acta. 2013 May;1832(5):618-25. doi: 10.1016/j.bbadis.2013.01.021. Epub 2013 Jan 31.
10
Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.
Mol Neurobiol. 2017 Sep;54(7):5213-5224. doi: 10.1007/s12035-016-0067-0. Epub 2016 Aug 30.
引用本文的文献
1
Abnormal iron metabolism in the zona incerta in Parkinson's disease mice.
J Neural Transm (Vienna). 2025 Mar 22. doi: 10.1007/s00702-025-02913-3.
2
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.
Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.
3
Sub-Chronic 30 mg/kg Iron Treatment Induces Spatial Cognition Impairment and Brain Oxidative Stress in Wistar Rats.
Biol Trace Elem Res. 2025 Jan 14. doi: 10.1007/s12011-024-04511-y.
4
Mitochondrial Aconitase and Its Contribution to the Pathogenesis of Neurodegenerative Diseases.
Int J Mol Sci. 2024 Sep 15;25(18):9950. doi: 10.3390/ijms25189950.
5
Parkinson's Disease and the Metal-Microbiome-Gut-Brain Axis: A Systems Toxicology Approach.
Antioxidants (Basel). 2021 Dec 28;11(1):71. doi: 10.3390/antiox11010071.
6
The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention.
Antioxidants (Basel). 2021 Dec 21;11(1):8. doi: 10.3390/antiox11010008.
7
Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.
Acta Pharmacol Sin. 2022 Jul;43(7):1686-1698. doi: 10.1038/s41401-021-00806-1. Epub 2021 Nov 22.
8
Off-resonance saturation as an MRI method to quantify mineral- iron in the post-mortem brain.
Magn Reson Med. 2022 Mar;87(3):1276-1288. doi: 10.1002/mrm.29041. Epub 2021 Oct 15.
9
Iron Deposition Characteristics of Deep Gray Matter in Elderly Individuals in the Community Revealed by Quantitative Susceptibility Mapping and Multiple Factor Analysis.
Front Aging Neurosci. 2021 Apr 14;13:611891. doi: 10.3389/fnagi.2021.611891. eCollection 2021.
10
New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.
Mol Neurobiol. 2021 Jun;58(6):2812-2823. doi: 10.1007/s12035-020-02277-7. Epub 2021 Jan 28.
本文引用的文献
1
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.
Brain. 2011 Mar;134(Pt 3):845-55. doi: 10.1093/brain/awq377. Epub 2011 Feb 9.
2
Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation.
Can J Physiol Pharmacol. 2010 Mar;88(3):187-96. doi: 10.1139/Y09-128.
3
Iron regulatory proteins: from molecular mechanisms to drug development.
Antioxid Redox Signal. 2010 Nov 15;13(10):1593-616. doi: 10.1089/ars.2009.2983.
4
Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.
Cell Res. 2010 Mar;20(3):345-56. doi: 10.1038/cr.2010.20. Epub 2010 Feb 2.
5
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18578-83. doi: 10.1073/pnas.0804373105. Epub 2008 Nov 14.
6
The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007.
Cell Tissue Bank. 2008 Sep;9(3):229-45. doi: 10.1007/s10561-008-9067-2. Epub 2008 Mar 18.
7
Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
Eur J Neurosci. 2007 May;25(9):2766-72. doi: 10.1111/j.1460-9568.2007.05515.x.
8
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.
J Neurochem. 2002 Oct;83(2):320-30. doi: 10.1046/j.1471-4159.2002.01118.x.
9
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
J Neural Transm. 1988;74(3):199-205. doi: 10.1007/BF01244786.
10
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
J Neurochem. 1991 Mar;56(3):978-82. doi: 10.1111/j.1471-4159.1991.tb02017.x.
Zotero 插件